0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
139.63%
Revenue growth above 1.5x 9698.HK's 2.98%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-6.61%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
No Data
No Data available this quarter, please select a different quarter.
27.23%
Positive operating income growth while 9698.HK is negative. John Neff might view this as a competitive edge in operations.
33.87%
Positive net income growth while 9698.HK is negative. John Neff might see a big relative performance advantage.
31.25%
EPS growth of 31.25% while 9698.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
31.25%
Diluted EPS growth of 31.25% while 9698.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.00%
Share reduction more than 1.5x 9698.HK's 0.15%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-121.39%
Negative OCF growth while 9698.HK is at 761.61%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-116.54%
Negative FCF growth while 9698.HK is at 94.79%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-87.78%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-88.16%
Negative 5Y CAGR while 9698.HK stands at 257.26%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-60.23%
Negative 3Y CAGR while 9698.HK stands at 78.82%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
13.79%
10Y OCF/share CAGR under 50% of 9698.HK's 543.50%. Michael Burry would worry about a persistent underperformance in cash creation.
38.22%
Below 50% of 9698.HK's 1345.79%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-49.02%
Negative 3Y OCF/share CAGR while 9698.HK stands at 965.19%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-264.27%
Negative 10Y net income/share CAGR while 9698.HK is at 74.14%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-5490.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-473.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-7.01%
Negative equity/share CAGR over 10 years while 9698.HK stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-24.07%
Negative 5Y equity/share growth while 9698.HK is at 341.54%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-19.64%
Negative 3Y equity/share growth while 9698.HK is at 98.03%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 9698.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 9698.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
84.92%
AR growth well above 9698.HK's 15.57%. Michael Burry fears inflated revenue or higher default risk in the near future.
-0.29%
Inventory is declining while 9698.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-10.95%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-6.95%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-36.45%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-22.46%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.